The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Veletri 1.5 Milligram Powder for Solution for Infusion



Janssen-Cilag International NVPA0885/001/002

Main Information

Trade NameVeletri 1.5 Milligram Powder for Solution for Infusion
Active SubstancesEPOPROSTENOL SODIUM
Dosage FormPowder for solution for infusion
Licence HolderJanssen-Cilag International NV
Licence NumberPA0885/001/002

Group Information

ATC CodeB01AC Platelet aggregation inhibitors excl. heparin
B01AC09 epoprostenol

Status

License statusAuthorised
Licence Issued16/09/2016
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back